Antiatherogenic effect of antioxidant polyphenols from Phellinus baumii in apolipoprotein E-deficient mice

Jung-Ran Noh1, In-Kyoung Lee, Yong-Hoon Kim

  • 1Laboratory Animal Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), University of Science and Technology (UST), Daejeon, Republic of Korea.

Abstract

Insights

Antioxidant polyphenols from Phellinus baumii (PBE) reduced triglycerides and inflammatory markers in apolipoprotein E-deficient mice. PBE ameliorated atherosclerotic lesion development, suggesting a potential antiatherosclerotic effect.

Area of Science:

  • Pharmacology
  • Immunology
  • Cardiovascular Research

Background:

  • Atherosclerosis is a chronic inflammatory disease characterized by lipid deposition and plaque formation in arteries.
  • Apolipoprotein E-deficient (apoE-/-) mice are a widely used model for studying atherosclerosis due to their spontaneous development of atherosclerotic lesions.
  • Oxidative stress and inflammation play critical roles in the pathogenesis of atherosclerosis.

Purpose of the Study:

  • To investigate the antiatherosclerotic effects of antioxidant polyphenols from Phellinus baumii (PBE).
  • To evaluate the impact of PBE on lipid profiles, inflammatory markers, and atherosclerotic lesion development in apoE-/- mice.

Main Methods:

  • Atherosclerosis was induced in apoE-/- mice using an atherogenic diet.
  • Mice were treated with PBE (500 mg/kg) or vehicle for 8 weeks.
  • Plasma lipids, cytokines (TNF-α, IL-6), aortic gene expression (VCAM-1, ICAM-1, TNF-α, IL-6, IL-1β), and atherosclerotic lesion size were analyzed.

Main Results:

  • PBE treatment significantly decreased triglyceride levels and suppressed plasma levels of TNF-α and IL-6.
  • PBE significantly inhibited the expression of adhesion molecules (VCAM-1, ICAM-1) and inflammatory cytokines in the aorta.
  • Reduced macrophage infiltration, lipid accumulation, and atherosclerotic lesions were observed in the aorta of PBE-treated mice.

Conclusions:

  • PBE exhibits significant antiatherosclerotic effects in apoE-/- mice.
  • The antiatherosclerotic activity of PBE is likely mediated by the inhibition of adhesion molecule and cytokine expression.
  • PBE demonstrates potential as a therapeutic agent for preventing or treating atherosclerosis.